Old Web
English
Sign In
Acemap
>
Paper
>
Evolocumab use in Europe: clinical guidelines vs. reimbursement thresholds – results from the HEYMANS study
Evolocumab use in Europe: clinical guidelines vs. reimbursement thresholds – results from the HEYMANS study
2021
Kausik K. Ray
Eric Bruckert
P. Filardi
C. Ebenbichler
A. Vogt
I Bridges
M. Sibartie
N. Dhalwani
Keywords:
Intensive care medicine
Evolocumab
Medicine
Reimbursement
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]